Skip to content

OceanFirst Financial OCFC Section 174 capitalized costs

Section 174 capitalized costs at other companies

Intellicheck, Inc. logo
Intellicheck, Inc.IDN
$0-100%
CorMedix logo
CorMedixCRMD
$5.16M
Esperion Therapeutics logo
Esperion TherapeuticsESPR
$26.13M-31.0%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$5.17M-73.7%
Exagen Inc. logo
Exagen Inc.XGN
$1.89M-35.6%
SB Financial Group logo
SB Financial GroupSBFG
$102K+13.3%

Other financials

Income statement

See full
Revenue$103.2M+5.4%
Net income$20.5M-4.7%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$137.0M-16.3%
Total debt$1.5B+29.7%
Total equity$1.7B-2.3%
Total assets$14.6B+9.4%

Cash flow

See full
Operating cash flow$25.2M+1,512%
CapEx$2.0M+5.2%
Free cash flow$23.3M+739%

Valuation

See full
Market cap$1.12B+60.4%
Enterprise value$2.51B+46.4%
P/E16.1×+8.1×
P/S2.7×+0.9×

Profitability

See full
Net margin17.1%-7.2pp
FCF margin25.9%

Returns & leverage

See full
Return on equity4.1%-1.4pp
Debt / equity0.9×+0.2×

Where this comes from

Reported directly by OceanFirst Financial in its filing.

Tagged under the XBRL concept ocfc:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts.

The official record: OceanFirst Financial’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about OceanFirst Financial's section 174 capitalized costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OceanFirst Financial's section 174 capitalized costs?
OceanFirst Financial (OCFC) reported section 174 capitalized costs of $4.97M in Q4 2025.
What is the long-term trend for OceanFirst Financial's section 174 capitalized costs?
Over 3 years (2022 to 2025), OceanFirst Financial's section 174 capitalized costs has grown at a 28.4% compound annual growth rate (CAGR), from $2.35M to $4.97M.
What does section 174 capitalized costs mean?
This reflects the deferred tax asset created by the capitalization and amortization of research and development costs for tax purposes, as required by specific tax code provisions. It represents the future tax deductions the company will receive as these capitalized costs are amortized over time. This metric highlights the tax impact of long-term investment in innovation and development activities.